ALLERGOL IMMUNOPATH 润色咨询

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

出版年份：1973 年文章数：1097 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：8.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2024-01-06 ms7000000177654165 来自广东省

    请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2022-09-27 ms4000000339340254

    打得开投稿网址吗，这两天一直进不去啊

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2022-09-06 ms8000001276651215

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：审稿很慢，到现在快3个月了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2021-12-29 Mia

    方法需要详细/具体到什么程度？

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    一般方法中要求写什么东西？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2179621, encodeId=f9aa21e96211f, content=请问投稿注册页面的防止垃圾信息，需要验证，究竟怎么验证啊，我这怎么看都是空白的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d4d9134751, createdName=ms7000000177654165, createdTime=Sat Jan 06 17:07:48 CST 2024, time=2024-01-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090602, encodeId=be7320906027b, content=打得开投稿网址吗，这两天一直进不去啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Tue Sep 27 10:47:44 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247448, encodeId=1be7124e44890, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：审稿很慢，到现在快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad7c6520674, createdName=ms8000001276651215, createdTime=Tue Sep 06 12:41:22 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100871, encodeId=477f11008e1a0, content=方法需要详细/具体到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100872, encodeId=6cb911008e274, content=一般方法中要求写什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832736, encodeId=ecd1832e3626, content=allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Mon Jul 11 16:21:13 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2016-07-11 ms5624929764890046

    allergologia et immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. allergologia et immunopathologia is the official journal of the spanish society of pediatric allergy and clinical immunology (seicap) and also of the latin american society of immunodeficiencies (lasid).

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分